Nasdaq biol

BIOLASE, Inc. (NASDAQ:BIOL) rose 11.9% to settle at $0.4700 after Nasdaq granted the company 180-day extension to meet minimum bid price requirement. The company also entered into favorable credit ...

Nasdaq biol. Biolase (BIOL) stock is flying high on Tuesday after announcing a massive deal for its dental lasers with Dental Care Alliance. BIOLASE down 30%, prices $4.5M stock offering (NASDAQ:BIOL) From ...

LAKE FOREST, Calif., June 21, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced today the extension of its digital learning webinar series ...

BIOLASE, Inc. (NASDAQ:BIOL) fell 43.3% to $1.85 in pre-market trading after the company announced pricing of $4.5 million underwritten public offering of Series J convertible redeemable preferred ...Of the funds tracked by Insider Monkey, Hal Mintz’s Sabby Capital has the biggest position in Biolase Inc (NASDAQ:BIOL), worth close to $0.1 million, comprising less than 0.1%% of its total 13F ...BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by Sonendo, Inc., through its wholly-owned subsidiary ...17 Nov, 2020, 09:00 ET. IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, completed its leadership council meeting of the Waterlase ...BIOLASE, Inc. (BIOL.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BIOLASE, Inc. | Nasdaq: BIOL | Nasdaq.Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific ...The Wall Street analyst predicted that Biolase's share price could reach $40.00 by May 31, 2024. The average Biolase stock price prediction forecasts a ...May-24-23 09:14AM. BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants. (PR Newswire) -39.91%. May-11-23 04:36PM. Biolase: Q1 Earnings Snapshot.

What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00.BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...LAKE FOREST, Calif., June 14, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that President and Chief Executive Officer, John Beaver and Chief Financial Officer, Jennifer Bright, have been invited to participate in the 2023 Virtual Healthcare Conference, presented by Maxim …Stock Ratings Screener · Free Ratings Newsletter. This page (NASDAQ:BIOL) was last updated on 11/30/2023 by ...BIOL technical analysis. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Biolase, Inc. is based on the most popular technical …

LAKE FOREST, Calif., June 21, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced today the extension of its digital learning webinar series ...BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ...BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript (Insider Monkey)-7.63%. Mar-28-23 04:16PM Biolase: Q4 Earnings Snapshot (AP Finance) 04:05PM Institutional Holdings information can be used to gauge the volatility and value on the company’s stock. $173.46 -0.20. VinFast Auto Ltd. Ordinary Shares. $8.11 +0.06 +0.75%. Find the latest ...FOOTHILL RANCH, Calif., Jan. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced preliminary 2021 fourth quarter revenue results that are ...Biolase (NASDAQ:BIOL) has filed to offering 125,000 unites, each consisting of:One Share of Series J Convertible Preferred Stock with a Liquidation Preference of $100.00 and One Warrant to... Investing.com; Aug 30, 2023 21:35

Best dental insurance in virginia.

LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared ...LAKE FOREST, Calif., Jan. 12, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor ...LAKE FOREST, Calif., Feb. 21, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has further advanced its market awareness and ...The 36-month beta value for BIOL is also noteworthy at 1.33. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”. The average price estimated by analysts for BIOL is $16.33, which is $14.66 above than the current price.

Real time Biolase (BIOL) stock price quote, stock graph, news & analysis. Nelly Dodson. December 4, 2023. Technologies. Biolase Inc (NASDAQ:BIOL) has a beta value of 1.20 and has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $3.29M, closed the recent trade at $1.43 per share which meant it gained $0.28 on the day or 24.35% during that session.Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...Jan 10, 2023 · LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre ... FOOTHILL RANCH, Calif., Jan. 12, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers announced an agreement with Dental Care Alliance (DCA), one of the largest ...BIOLASE, Inc. (NASDAQ:BIOL) was down, falling 38% to $2.0095 after the company announced pricing of a $4.5 million underwritten public offering of Series J Convertible Redeemable Preferred Stock ...Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 28.5% to $0.7451 in pre-market trading after the company reported better-than-expected Q1 sales.Posted by Techdows on Nov 30th, 2023. StockNews.com lowered shares of BIOLASE ( NASDAQ:BIOL – Free Report) from a hold rating to a sell rating in a report issued on Wednesday. Separately, Benchmark cut their price objective on shares of BIOLASE from $10.00 to $4.00 in a research report on Wednesday, September 20th. Get BIOLASE alerts:BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the ...BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ...

Graphite Bio, Inc. (Nasdaq – GRPH) Under the terms of the agreement, Graphite Bio will merge with LENZ Therapeutics in an all-stock transaction. Under the …

The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on May 31, 2023.The analyst firm set a price target for $0.40 expecting BIOL to fall to within 12 months (a ...4 Oct 2012 ... Nasdaq: BIOL. PAGE 1. Exhibit 99.1. The BIOLASE. Total Solution. The ... Eliminates accidental sticks with contaminated burs. BIOLASE'S Waterlase ...May-24-23 09:14AM. BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants. (PR Newswire) -39.91%. May-11-23 04:36PM. Biolase: Q1 Earnings Snapshot.How are hedge funds trading Biolase Inc (NASDAQ:BIOL)? Heading into the fourth quarter of 2020, a total of 4 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 33 ...morningstar.com - November 1 at 12:25 PM. BIOLASE, Inc. (BIOL) ca.finance.yahoo.com - October 18 at 8:14 AM. BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. finance.yahoo.com - September 18 at 5:11 PM.Nov 29, 2023 · What is BIOLASE's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00. About · Highlight. A world's leading dental laser company. Industry · Exchange. NASDAQ · Listing Date. 11/12/1992 · Established Date · Full-time Employees.Institutional Holdings information can be used to gauge the volatility and value on the company’s stock. $173.46 -0.20. VinFast Auto Ltd. Ordinary Shares. $8.11 +0.06 +0.75%. Find the latest ...

Ex div calendar.

Vbiax vanguard.

BIOLASE (NASDAQ:BIOL) Share Prices Have Dropped 88% In The Last Five Years May 15, 2021 — 03:29 am EDT Written by Simply Wall St for Simply Wall St …The image below, which you can click on for greater detail, shows that BIOLASE had debt of US$13.5m at the end of September 2021, a reduction from US$16.1m over a year. But it also has US$33.4m in ...01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...IRVINE, Calif., April 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a leader in medical devices, today announced that it expects to join the fight against the coronavirus (COVID-19 ...06 May, 2021, 09:00 ET. IRVINE, Calif., May 6, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, announced today its Waterlase Pediatric Dental Academy (WPDA ...At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ...FOOTHILL RANCH, Calif., March 23, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that President and CEO, John Beaver, has been invited to ...UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:May 24, 2023...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financial and operating results on Thursday, August 10, 2023, after the ... ….

BIOL After-Hours Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary ... (NASDAQ: BIOL), a global leader in dental lasers, today announced the appointment of Russell Morrow, D.D.S. as Chief Dental Officer ("CDO"), effective November 1, 2022. Dr. Samuel Low, who has served as Chief Dental Officer since 2016, will be taking on a new role as Vice President, Clinical Strategic Alliances, where he will focus on …How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997.Nov 27, 2023 · The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on Wednesday, May 31, 2023.The analyst firm set a price target for 0.40 expecting BIOL to fall to within 12 months ... Jan 18, 2023 · BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between ... FOOTHILL RANCH, Calif., March 25, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year .../PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will be presenting at the Benchmark Company Discovery...BIOL U.S.: Nasdaq. Biolase Inc. Watchlist. Alert. NEW. Set a price target alert ... Real-time last sale data for U.S. stock quotes reflect trades reported through ...May 12, 2023 · Biolase (NASDAQ: BIOL) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news for investors in BIOL stock is the company’s ... Nasdaq biol, [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1]